Dr. Papadopoulos is the world’s leading authority on the structure, function and pharmacology of TSPO, and his research has elucidated the role of TSPO as a main control element for the synthesis of endogenous neurosteroids.
Dr. Papadopoulos is a graduate of the School of Pharmacy of the University of Athens. He completed his PhD in Health and Life Science at Université Pierre et Marie Curie, Paris, and post-doctoral studies in France and Australia. In 1988, he joined the faculty of Georgetown University School of Medicine, where he rose through the ranks to become Professor and Chair of the Department of Biochemistry and Molecular Biology, Associate Vice President for Research and then Director of the Biomedical Graduate Research Organization at Georgetown University Medical Centre. In 2007, he moved to Montreal as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre, and Professor of Medicine at McGill University where he held the Canada Research Chair in Biochemical Pharmacology and the Phil Gold Chair in Medicine.
Dr. Papadopoulos’ research focuses on the pharmacology of steroid hormone biosynthesis in relation to endocrine pathologies, male reproductive disorders, neuropathologies and cancer as well as the identification of new molecules targeting key elements in diseases where steroids play a determining role. This work has been supported by grants and contracts from the National Institutes of Health, the National Science Foundation, US Department of Defense, Canadian Institutes of Health Research, Canadian Foundation of Innovation, private foundations, as well as the pharmaceutical industry.
Current role
AI Scientist at Ekkel AI
Research Scientist at Mazumdar Shaw Medical Foundation (MSMF)
Research Resources Team Member at Australian Medical Students' Association
Data Science Vice President at PS AI Labs
ceo / Principal Scientist at Mecanica Scientific Services Corporation
Access the worlds's biggest network of public org charts
Learn more